IndRead |Latest Updates and Breaking News Today in India

Latest Approach to Vaccine | Molecule Blocking AIDS Virus

Scientists have identified a molecule that which can stop the HIV virus infection, an invention that potentially might guide to newest analysis for patients and substitute to a vaccine.

A new study has been developed to block the AIDS virus and can stop the very infectious virus, Human Immunodeficiency Virus (HIV). This is the medical miracle that can prove to treat the patients with AIDS and even proved as a vaccine that turned out the HIV. This is an exciting new study with its simplifications that which those molecules has the tendency to block the spreading virus. Have a look here to have a clear view about the technology that they have identified.

Even though leading with the developed technology, no one has found the cure for HIV virus. They are trying out for about three decades to identify an effective vaccine for Human Immunodeficiency Virus that which causes the dreadful AIDS.

Fortunately, a team from the Scripps Research Institute and from the other institutions said that they discovered a way to avoid the HIV from infecting cells by using an advance technology that looks like the gene therapy or transfer rather than extracingt an immune response.

Michael Farza, a professor of infectious diseases at the Scripps Research Institute in Jupiter, Fla., who is the lead author of the study there said, “It is absolutely 100% effective. There is no question that it is by far the broadest entry inhibitor out there.”

They said that the experiment has done on those four rhesus monkeys and it is successful but not yet on humans. They said that they affected the monkeys with the hybrid version of HIV that which is sent into them for four times. The protein which they sent into those monkeys protected them for about 40 weeks.

The director of the National Institute of Allergy and Infectious Diseases, Anthony Fauci said, “This innovative research holds promise for moving us toward two important goals: achieving long-term protection from HIV infection, and putting HIV into sustained remission in chronically infected people.”